Masahiro Natsuaki

发表

Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-3.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Circulation. Cardiovascular interventions.

Prognostic Impact of Baseline Hemoglobin Levels on Long‐Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions

T. Akasaka, K. Tanabe, Takeshi Kimura, 2019, Journal of the American Heart Association.

Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies

Takeshi Kimura, T. Morimoto, H. Shiomi, 2017, Circulation.

Glycemic variability and cardiac remodeling in patients with acute myocardial infarction.

K. Node, Masahiro Natsuaki, 2015, Circulation journal : official journal of the Japanese Circulation Society.

Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial

H. Okayama, K. Tanabe, Takeshi Kimura, 2020, Cardiovascular Intervention and Therapeutics.

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.

H. Okayama, K. Tanabe, Takeshi Kimura, 2019, JAMA.

Periprocedural Stroke After Coronary Revascularization (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).

Takeshi Kimura, T. Morimoto, H. Shiomi, 2020, The American journal of cardiology.

Duration of Dual Antiplatelet Therapy and Long-Term Clinical Outcome After Coronary Drug-Eluting Stent Implantation: Landmark Analyses From the CREDO-Kyoto PCI/CABG Registry Cohort-2

A. Kastrati, M. Nobuyoshi, R. Nohara, 2012, Circulation. Cardiovascular interventions.

Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke

T. Akasaka, K. Tanabe, Takeshi Kimura, 2019, Journal of the American Heart Association.

Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives

K. Node, K. Yokoi, Masahiro Natsuaki, 2022, Cardiovascular Intervention and Therapeutics.

Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention.

K. Tanabe, Takeshi Kimura, Y. Morino, 2019, The American journal of cardiology.

Sex Differences in Long-Term Clinical Outcomes in Patients With Atrial Fibrillation Undergoing Coronary Stent Implantation.

T. Akasaka, K. Tanabe, Takeshi Kimura, 2018, Circulation journal : official journal of the Japanese Circulation Society.

Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.

M. Nobuyoshi, M. Horie, R. Nohara, 2014, The American journal of cardiology.

Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.

K. Tanabe, Y. Ikari, Y. Morino, 2022, JAMA cardiology.

Risk Factors and Outcomes of Recurrent Drug‐Eluting Stent Thrombosis: Insights From the REAL‐ST Registry

M. Toyofuku, S. Saito, G. Nakazawa, 2021, Journal of the American Heart Association.

Effect of Heart Failure on Long‐Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Journal of the American Heart Association.

Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2

A. Kastrati, M. Nobuyoshi, M. Horie, 2015, PloS one.

Antiplatelet therapy discontinuation and stent thrombosis after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.

Y. Hayashi, M. Nobuyoshi, Takeshi Kimura, 2015, International journal of cardiology.

Nodular Calcification in Saphenous Vein Graft Successfully Treated by Percutaneous Coronary Intervention

Masahiro Natsuaki, T. Serikawa, Yusuke Yamamoto, 2018, Case reports in cardiology.

Long-Term Outcomes After Coronary Stent Implantation in Patients Presenting With Versus Without Acute Myocardial Infarction (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2).

Takeshi Kimura, T. Morimoto, H. Shiomi, 2015, The American journal of cardiology.

β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction

M. Nobuyoshi, Takeshi Kimura, T. Kita, 2013, Cardiovascular Intervention and Therapeutics.

Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation

Takeshi Kimura, T. Morimoto, Masahiro Natsuaki, 2013 .

Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Very Short Dual Antiplatelet Therapy after Drug-eluting Stent Implantation in Patients with High Bleeding Risk: Insight from the STOPDAPT-2 Trial.

H. Okayama, K. Tanabe, Takeshi Kimura, 2019, Circulation.

Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients with Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3).

Takeshi Kimura, T. Morimoto, H. Shiomi, 2021, The American journal of cardiology.

Effects of Age and Sex on Clinical Outcomes After Percutaneous Coronary Intervention Relative to Coronary Artery Bypass Grafting in Patients With Triple-Vessel Coronary Artery Disease

Takeshi Kimura, T. Morimoto, H. Shiomi, 2016, Circulation.

Outcomes of Drug-Eluting Stent Thrombosis After Treatment for Acute Versus Chronic Coronary Syndrome.

S. Saito, G. Nakazawa, K. Node, 2021, JACC. Cardiovascular interventions.

Outcomes After First- Versus Second-Generation Drug-Eluting Stent Thrombosis (from the REAL-ST Registry).

S. Saito, G. Nakazawa, Takeshi Kimura, 2020, The American journal of cardiology.

Second-Generation vs. First-Generation Drug-Eluting Stents in Patients With Calcified Coronary Lesions　- Pooled Analysis From the RESET and NEXT Trials.

T. Akasaka, K. Tanabe, Takeshi Kimura, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Second-generation versus first-generation drug-eluting stents in patients with and without diabetes mellitus: pooled analysis from the RESET and NEXT trials

T. Akasaka, K. Tanabe, Takeshi Kimura, 2016, Cardiovascular Intervention and Therapeutics.

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Different types of Kounis syndrome caused by different episodes of bee sting anaphylaxis: Misfortunes never come singly

K. Node, K. Yokoi, Masahiro Natsuaki, 2022, Journal of Cardiology Cases.

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention

K. Tanabe, Takeshi Kimura, Y. Ikari, 2021, Circulation. Cardiovascular interventions.

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With versus Without Chronic Kidney Disease.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Serum Albumin and Bleeding Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (from the HAGAKURE-ACS Registry).

K. Node, K. Yokoi, Masahiro Natsuaki, 2021, The American journal of cardiology.

Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2

Takeshi Kimura, Y. Morino, T. Morimoto, 2020, Cardiovascular Intervention and Therapeutics.

Clopidogrel Monotherapy vs. Aspirin Monotherapy Following Short-Term Dual Antiplatelet Therapy in Patients Receiving Everolimus-Eluting Coronary Stent Implantation.

K. Tanabe, Takeshi Kimura, Y. Ikari, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk

Takeshi Kimura, T. Morimoto, H. Shiomi, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation

K. Tanabe, Takeshi Kimura, Y. Morino, 2020, PloS one.

Comparison of 3-year clinical outcomes after transradial versus transfemoral percutaneous coronary intervention

Takeshi Kimura, T. Morimoto, H. Shiomi, 2012, Cardiovascular Intervention and Therapeutics.

Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2.

M. Onoe, Takeshi Kimura, T. Morimoto, 2013, Atherosclerosis.

Long-term outcomes after percutaneous coronary intervention for chronic total occlusion (from the CREDO-Kyoto registry

M. Nobuyoshi, Takeshi Kimura, T. Morimoto, 2021 .

Long-term outcomes after percutaneous coronary intervention for chronic total occlusion (from the CREDO-Kyoto registry cohort-2).

M. Nobuyoshi, Takeshi Kimura, T. Morimoto, 2013, The American journal of cardiology.

Beta-blocker Therapy and Cardiovascular Outcomes in Patients Who Have Undergone Percutaneous Coronary Intervention After ST-elevation Myocardial Infarction Short title: Beta-blockers in Myocardial Infarction, Word count for text: 2,589 words

T. Kita, T. Morimoto, H. Shiomi, 2018 .

Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.

Takeshi Kimura, T. Kita, T. Morimoto, 2012, Circulation journal : official journal of the Japanese Circulation Society.

Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).

Takeshi Kimura, T. Morimoto, Masahiro Natsuaki, 2012, American Journal of Cardiology.

Impact of Angiographic Residual Stenosis on Clinical Outcomes After New‐Generation Drug‐Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials

T. Akasaka, K. Tanabe, Takeshi Kimura, 2018, Journal of the American Heart Association.

A Novel Predictive Model for In-Hospital Mortality Based on a Combination of Multiple Blood Variables in Patients with ST-Segment-Elevation Myocardial Infarction

K. Node, Masahiro Natsuaki, A. Kawaguchi, 2020, Journal of clinical medicine.

Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis

Takeshi Kimura, Masahiro Natsuaki, N. Saito, 2013, Heart and Vessels.

Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan　- From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-2.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2020, Circulation Journal.

Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial

T. Akasaka, K. Tanabe, Takeshi Kimura, 2015, Circulation. Cardiovascular interventions.

Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial)

J. Oyama, K. Node, Masahiro Natsuaki, 2016, Heart and Vessels.

Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis: A case report and review of the literature

Takeshi Kimura, Masahiro Natsuaki, N. Saito, 2016 .

Development of an application for management of drug holidays in perioperative periods

Y. Narisawa, Masahiro Natsuaki, H. Noshiro, 2020, Medicine.

Two-year outcome of a randomized trial comparing second-generation drug-eluting stents using biodegradable or durable polymer.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2014, Journal of the American Medical Association (JAMA).

AnticoagulantandAntiplateletTherapyinPatientsWithAtrial Fibrillation Undergoing Percutaneous Coronary Intervention

M. Nobuyoshi, M. Horie, R. Nohara, 2014 .

Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent

P. Smits, Takeshi Kimura, T. Morimoto, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention

K. Tanabe, Takeshi Kimura, Y. Ikari, 2021, Circulation. Cardiovascular interventions.

Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization.

Takeshi Kimura, T. Morimoto, Masahiro Natsuaki, 2011, Circulation journal : official journal of the Japanese Circulation Society.

Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction

K. Node, Masahiro Natsuaki, N. Watanabe, 2022, Frontiers in Cardiovascular Medicine.

Comparison of Clinical Characteristics of Stent Thrombosis Between the Right Coronary Artery and the Left Coronary Artery　- A Subanalysis of the REAL-ST Registry.

S. Saito, G. Nakazawa, Takeshi Kimura, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT).

T. Akasaka, K. Tanabe, Takeshi Kimura, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.

S. Saito, G. Nakazawa, Takeshi Kimura, 2019, Circulation. Cardiovascular interventions.

Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry.

S. Saito, G. Nakazawa, H. Shiomi, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Title Comparison of Long-Term Outcome After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery Disease (from the CREDO-Kyoto PCI/CABG Registry

Shimamoto, M. Nobuyoshi, M. Horie, 2019 .

Thrombotic Risk Stratification and Intensive Statin Therapy for Secondary Prevention of Coronary Artery Disease　- Insights From the REAL-CAD Study.

M. Matsuzaki, Takeshi Kimura, H. Daida, 2022, Circulation Journal.

Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention.

T. Morimoto, N. Watanabe, Ko Yamamoto, 2022, JACC. Cardiovascular interventions.

Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial.

T. Akasaka, K. Tanabe, Takeshi Kimura, 2013, Journal of the American College of Cardiology.

Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial

K. Node, T. Morimoto, Masahiro Natsuaki, 2019, Scientific Reports.

JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease.

F. Otsuka, T. Akasaka, A. Hirayama, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Recurrence of pulmonary embolism in young man with retroperitoneal tumor despite insertion of temporary IVC filter.

Masahiro Natsuaki, K. Numaguchi, Y. Nakashima, 2009, Circulation Journal.

Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI

H. Okayama, K. Tanabe, Y. Morino, 2023, JACC. Asia.

Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort

H. Okayama, K. Tanabe, Takeshi Kimura, 2022, Circulation. Cardiovascular interventions.

Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the CREDO-Kyoto registry cohort-2

Takeshi Kimura, T. Morimoto, H. Shiomi, 2016, Cardiovascular Intervention and Therapeutics.

Influence of Sex on Long-Term Outcomes After Implantation of Bare-Metal Stent: A Multicenter Report From the Coronary Revascularization Demonstrating Outcome Study-Kyoto (CREDO-Kyoto) Registry Cohort-1

Takeshi Kimura, T. Morimoto, H. Shiomi, 2015, Circulation.

One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial

K. Tanabe, Takeshi Kimura, Y. Morino, 2015, Cardiovascular Intervention and Therapeutics.

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores

T. Akasaka, K. Tanabe, Takeshi Kimura, 2018, Journal of the American Heart Association.

Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal Stent: Long-Term (5–7 Years) Follow-Up of the Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2

M. Nobuyoshi, M. Horie, R. Nohara, 2014, Circulation. Cardiovascular interventions.

Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents: 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET)

Y. Hayashi, T. Akasaka, K. Tanabe, 2012, Circulation.

Drug-eluting stent thrombosis: current and future perspectives

Takeshi Kimura, Masahiro Natsuaki, K. Ando, 2021, Cardiovascular Intervention and Therapeutics.

Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration

Takeshi Kimura, T. Morimoto, H. Shiomi, 2017, PloS one.

Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction.

K. Node, K. Yokoi, Masahiro Natsuaki, 2021, International journal of cardiology.

Coronary Artery Disease Without Standard Cardiovascular Risk Factors.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention

H. Okayama, M. Nishino, K. Tanabe, 2023, Circulation. Cardiovascular interventions.

Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2).

M. Nobuyoshi, Takeshi Kimura, T. Kita, 2012, The American journal of cardiology.

Biodegradable Polymer Drug-Eluting Stent versus Contemporary Durable Polymer Drug-Eluting Stents in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.

Takeshi Kimura, J. Abbott, Masahiro Natsuaki, 2019, European heart journal. Quality of care & clinical outcomes.

Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization

M. Toyofuku, M. Onoe, Y. Kihara, 2022, JACC. Asia.

Shimamoto, M. Nobuyoshi, M. Horie, 2018 .

Spontaneous Internal Mammary Artery Graft Dissection Triggered by Emotional Stress

K. Node, Masahiro Natsuaki, Aiko Komatsu, 2019, JACC. Case reports.

De-Escalation Therapy After PCI in ACS Patients With Chronic Kidney Disease

K. Node, Masahiro Natsuaki, 2023, JACC. Asia.

Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi‐vessel coronary revascularization (from the CREDO‐Kyoto PCI/CABG registry/cohort‐2)

Takeshi Kimura, T. Morimoto, H. Shiomi, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)

K. Yokoi, Masahiro Natsuaki, T. Wakatsuki, 2023, European Journal of Medical Research.

Sirolimus-eluting stent implantation for ostial right coronary artery lesions: five-year outcomes from the j-Cypher registry

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2014, Cardiovascular Intervention and Therapeutics.

Prognostic impact of follow‐up serum albumin after acute myocardial infarction

K. Node, Masahiro Natsuaki, A. Kawaguchi, 2021, ESC heart failure.

Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).

M. Nobuyoshi, M. Horie, T. Kita, 2012, The American journal of cardiology.

β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2013, International journal of cardiology.

Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis: A case report and review of the literature

Takeshi Kimura, Masahiro Natsuaki, J. Tazaki, 2017 .

Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis

Masahiro Natsuaki, J. Tazaki, Shin Watanabe, 2013 .

Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT Trial.

T. Akasaka, K. Tanabe, Y. Morino, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary Intervention.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2021, The American journal of cardiology.

Effects of Age and Sex on Clinical Outcomes After Percutaneous Coronary Intervention Relative to Coronary Artery Bypass Grafting in Patients With Triple-Vessel Coronary Artery Disease

Takeshi Kimura, T. Morimoto, H. Shiomi, 2016, Circulation.

Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease: From the CREDO-Kyoto PCI/CABG registry Cohort-3

H. Shiomi, Ko Yamamoto, Masahiro Natsuaki, 2022, PloS one.

State-of-the-art percutaneous coronary intervention for left main coronary artery disease in Japan.

Masahiro Natsuaki, Kenichi Tsujita, Ken Kozuma, 2024, Cardiovascular intervention and therapeutics.

Statin Discontinuation After Coronary Revascularization.

M. Toyofuku, H. Shiomi, Ko Yamamoto, 2023, The American journal of cardiology.

Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction.

K. Node, K. Yokoi, Masahiro Natsuaki, 2021, International journal of cardiology.

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

John E. Poremba, H. Randeva, P. Borne, 2024, The Lancet.

Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry

S. Saito, G. Nakazawa, H. Shiomi, 2023, Thrombosis Journal.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2015, Circulation.